newsfilter
← Latest News
GlobeNewswire·

Impact BioMedical Announces License Agreement with ProPhase Labs to Produce and Distribute Viral-Fighting Compound Equivir

HENRIETTA, N.Y., June 28, 2022 (GLOBE NEWSWIRE) -- Impact Biomedical, Inc., a wholly owned subsidiary of DSS, Inc. (NYSE:DSS), along with its scientific research partner Global Research and Discovery Group Sciences (GRDG), announced today that it signe